40 views | 22 Feb 2023
Session 5: Vascular Disease
Session 5: Vascular Disease
Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension
Hemodynamic Rounds Live: Case study, mitral stenosis and pulmonary hypertension
PVOD/PCH and Other Rare Causes of Pulmonary Hypertension
Session 3: EP
Interventional Potts shunt & stenting of closed ductus
RDN:WIN. A Clear Win To Managing Hypertension Patients (EuroPCR follow up)
RDN:WIN. A Clear Win To Managing Hypertension Patients (EuroPCR follow up)
Pulmonary Arterial Hypertension is it still Perceived as a Rare Disease ?
There are now effective therapies for resistant hypertension with respect to renal denervation
Correlation Between Tumor Necrosis Factoralpha and Cardiovascular Complication in Rheumatoid Arthritis Patients - Mohamed Sayed Bashandy
Summary Correlation Between Tumor Necrosis Factoralpha and Cardiovascular Complication...
Genetics and PAH - Research and Clinical Applications
Imaging the Right Heart in Pulmonary Hypertension: Part 1 - Echo
Hypertension Guidelines: Approach to management of hypertension according to ESC Guidelines (Part 1)
Hypertension Guidelines: What are the blood pressure targets of pharmacotherapy?
Evaluation of CTEPH: VQ Scans and Planar Angiography
The Hypertension clinic is set up by a clinical cardiologist and interventionalist
The key takeaway from this consensus statement is that a multidisciplinary hypertension
Moving PHoward to Improve Prognosis of PAH Patients - Management Strategy
Fibroblast Growth Factor-23 as a Possible Cause of Left Ventricular Hypertrophy and Pulmonary Hypertension in Hemodialysis Patients - Tamer Taha
Summary Fibroblast Growth Factor-23 as a Possible Cause of Left Ventricular Hypertrophy...